PRESS RELEASE published on 10/22/2025 at 13:30, 9 months 27 days ago Medicus Pharma Ltd. Announces First Patient Treated in United Arab Emirates (UAE) Sknjct-004 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin Medicus Pharma enrolls first patient in SKNJCT-004 phase 2 clinical study for non-invasive BCC treatment in UAE with Cleveland Clinic Abu Dhabi as lead investigator Clinical Study Medicus Pharma SKNJCT-004 BCC Treatment Cleveland Clinic Abu Dhabi
BRIEF published on 10/13/2025 at 13:35, 10 months 5 days ago Medicus Pharma Ltd. présentera au Maxim Growth Summit 2025 Conférence Sur Les Biotechnologies Medicus Pharma Teverelix Sommet Maxim Growth Injection Cutanée
BRIEF published on 10/13/2025 at 13:35, 10 months 5 days ago Medicus Pharma Ltd. to Present at Maxim Growth Summit 2025 Biotech Conference Medicus Pharma Teverelix Maxim Growth Summit Skinject
PRESS RELEASE published on 10/13/2025 at 13:30, 10 months 5 days ago Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025 Medicus Pharma Ltd. CEO to join fireside chat at Maxim Growth Summit, discussing clinical development programs of Skinject (skin diseases) and Teverelix (advanced prostate cancer) Clinical Development Fireside Chat CEO Medicus Pharma Ltd. Maxim Growth Summit
BRIEF published on 10/07/2025 at 13:35, 10 months 11 days ago Medicus Pharma participera au sommet des family offices de Dubaï Développement Clinique Intelligence Artificielle Innovations Biotechnologiques Medicus Pharma Sommet Des Family Offices
BRIEF published on 10/07/2025 at 13:35, 10 months 11 days ago Medicus Pharma to Participate in Dubai Family Office Summit Artificial Intelligence Clinical Development Biotech Innovations Medicus Pharma Family Office Summit
PRESS RELEASE published on 10/07/2025 at 13:30, 10 months 11 days ago Medicus Pharma Ltd. to Present at the Family Office Summit in Dubai, UAE Dr. Raza Bokhari, Executive Chairman & CEO of Medicus, to discuss biotech innovation and wealth transfer at Family Office Summit in Dubai Biotech Innovation Family Office Summit Medicus Raza Bokhari Wealth Transfer
BRIEF published on 09/29/2025 at 13:35, 10 months 19 days ago Medicus Pharma Ltd. obtient le soutien de la FDA pour le développement de Skinject Essais Cliniques Approbation De La FDA Medicus Pharma Carcinome Basocellulaire Développement De Skinject
BRIEF published on 09/29/2025 at 13:35, 10 months 19 days ago Medicus Pharma Ltd. Gains FDA Support for Skinject Development FDA Approval Clinical Trials Medicus Pharma Basal Cell Carcinoma Skinject Development
PRESS RELEASE published on 09/29/2025 at 13:30, 10 months 19 days ago Medicus Pharma Ltd. Receives Positive Feedback From the Food and Drug Adminstration (FDA) Type C Meeting Supporting the Development of Skinject FDA agrees to 505(b)(2) pathway for Medicus Pharma's Skinject D-MNA to treat BCC, positive Type C meeting feedback, SKNJCT-003 patient recruitment aims, EOP2 request in Q1 2026 FDA Clinical Study Medicus Pharma Skinject D-MNA BCC
Published on 08/19/2026 at 12:30, 28 minutes ago Wolfden Announces Positive Precious Metal Results at Canoe Landing
Published on 08/19/2026 at 09:05, 3 hours 53 minutes ago BioNxt Advances Cladribine Clinical Program with Completion of the Investigational Medicinal Product Dossier (IMPD) Ahead of Human Clinical Studies
Published on 08/19/2026 at 07:00, 5 hours 58 minutes ago Caldwell Strengthens Life Sciences and Healthcare Practice with Addition of Olga Kozlova in Dubai
Published on 08/19/2026 at 04:00, 8 hours 58 minutes ago Momenta, XHEART, and QNX Build an Autonomous Driving Platform Certified to Global Safety Standards
Published on 08/18/2026 at 23:10, 13 hours 48 minutes ago Secure Blockchain Signs Agreement to Sell Delivery Trust(R) Business
Published on 08/19/2026 at 12:29, 28 minutes ago Start of the Nexum Group – an Integrated Residential Property Developer in Germany's Top-7 Cities
Published on 08/19/2026 at 12:10, 48 minutes ago EQS-Adhoc: SCP Standard Capital Partners AG launches a sale process for its operating investments and publishes preliminary figures for the first half of 2026
Published on 08/19/2026 at 12:05, 53 minutes ago Wultra Named the Only Sample Vendor for Post-Quantum Authentication in Gartner® Hype Cycle™ -- Two Years Running
Published on 08/18/2026 at 18:00, 18 hours 58 minutes ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 19 hours 13 minutes ago Mise à disposition du rapport financier annuel 2025-26
Published on 08/18/2026 at 11:15, 1 day 1 hour ago GUILLEMOT CORPORATION | Déclaration hebdomadaire des transactions sur actions propres du 10 au 14 août 2026
Published on 08/18/2026 at 11:15, 1 day 1 hour ago GUILLEMOT CORPORATION | Weekly report share buyback from August 10 to August 14 2026
Published on 08/17/2026 at 19:45, 1 day 17 hours ago Aéroports de Paris S.A - July 2026 traffic figures